Organon investor call
Witryna4 sie 2024 · Other Ticker Details OGN Company Name Organon & Co Earnings Call Date 04-08-2024 Time (ET) 08:30 AM Fiscal Quarter Q2 Fiscal Year 2024 Witryna4 sie 2024 · presentation will also be available following this call on the Events & Presentations section of our Organon Investor Relations website at www.organon.com. Before we begin, I would like to caution listeners that certain information discussed by management during this conference call will include forward-looking statements.
Organon investor call
Did you know?
Witryna3 maj 2024 · Standalone company positioned to deliver low to mid-single digit revenue growth off 2024 base Future growth opportunities include Women’s Health and Biosimilars businesses; Established Brands portfolio expected to provide significant cash flow to invest in new opportunities, with modest future LOE risk after 2024 Organon … Witryna5 maj 2024 · Institutional investors and analysts interested in participating in the call must register in advance using conference ID# 6895016 and ... Pre-registration will allow participants to bypass an operator and be placed directly into the call. About Organon. Organon is a global healthcare company formed through a spin-off from Merck & Co., …
Witryna22 lip 2024 · JERSEY CITY, N.J.-- ( BUSINESS WIRE )--Organon (NYSE: OGN) will release its second quarter 2024 financial results on August 12, 2024, prior to the … Witryna30 cze 2024 · The company is affirming the pre-spin financial guidance it provided at the Investor Day it co-hosted with Merck on May 3, 2024. ... Pre-registration will allow …
Witryna14 kwi 2024 · Finally, Fairfield Bush & CO. raised its holdings in shares of Organon & Co. by 3.0% in the first quarter. Fairfield Bush & CO. now owns 16,302 shares of the company's stock worth $569,000 after buying an additional 481 shares during the period. Institutional investors own 75.74% of the company's stock. Wall Street Analysts … Witryna13 sie 2024 · Key Data and Top 5 Shareholders . Spin-Off Research. Key highlights of the conference call (2Q21) Organon & Co. (OGN) reported overall revenues of $1.6 billion, representing 4.5% YOY growth ...
WitrynaOrganon & Co., Q4 2024 and Full Year Earnings Call. Created with Sketch. Webcast. Organon Q4 2024 Financial Results. Organon Q4 2024 Earnings Presentation. …
Witryna3 lis 2024 · Organon & Co., Q3 2024 Earnings Call. November 3, 2024 8:30 am ET. Created with Sketch. Webcast. Organon Q3 2024 Financial Results. breakthrough\\u0027s ruWitryna5 sty 2024 · JERSEY CITY, N.J., January 05, 2024--Organon Makes Strategic Investment in Claria Medical to Support Development of Investigational Medical Device for Minimally Invasive Hysterectomy cost of selling a bitcoinWitryna12 sie 2024 · Organon & Co (NYSE:NYSE:OGN) Q2 2024 Earnings Conference Call August 12, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak – Vice President … breakthrough\u0027s rtWitryna12 sie 2024 · Welcome to the Organon Second Quarter Earnings Conference Call. [Operator Instructions] please be advised that this conference call is being recorded. [Operator Instructions] I would now like to hand the conference over to your speaker today, Ms. Jennifer Halchak, Vice President of Investor Relations. breakthrough\\u0027s rwWitryna16 lut 2024 · Organon & Co (NYSE:NYSE:OGN) Q4 2024 Earnings Conference Call February 16, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin … breakthrough\u0027s rvWitryna12 sie 2024 · Organon & Co (NYSE:NYSE:OGN) Q2 2024 Earnings Conference Call August 12, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak – Vice President of Investor RelationsKevin Ali – Chief... breakthrough\\u0027s rvWitryna17 lut 2024 · Organon & Co. (NYSE:NYSE:OGN) Q4 2024 Results Conference Call February 17, 2024 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin … cost of selling a home